This summary covers recent health news, including the slow adoption of gene therapy for sickle cell, Glenview Capital's ...

The withdrawal comes after postmarketing studies showed that the risks of side effects were greater than the benefits.

The withdrawal comes after postmarketing studies showed that the risks of side effects were greater than the benefits.

Officials hosted a tour Friday and launched a groundbreaking pediatric treatment for sickle cell disease. Yunigen officials, including Chief Executive Officer and Vice President Charles Otieno and ...

September is sickles cell awareness month. One Chicago woman who was diagnosed at birth is raising funds and awareness with a ...

Pfizer’s abrupt withdrawal of Oxbryta, a drug for sickle cell disease, has sent shockwaves through the medical community.

Meanwhile, in Lawton, about a dozen people showed up at the Abundant Life Christian Church to donate blood for the Sickle ...

Beam Therapeutics' pipeline shows promise but remains in early stages with no clinical trial data yet available. Find out why ...